BCN Peptides is thrilled to announce our participation in #DCATWeek 2024 in NYC from March 18th-21st, a premier event for the bio and pharmaceutical manufacturing industry. Eager to connect with industry professionals, our team (Jordi Piro, Stephanie Wang & Yaiza Martínez) welcomes networking opportunities.
If you’re attending DCAT, let’s schedule a meeting and explore potential collaborations! See you at #DCAT2024!

Recent regulatory inspections by European Authorities culminated in the successful acquisition of two GMP certificates:

· Part I underscores our commitment to sterile peptides and contract laboratory excellence, aligning with Annex 1 standards.
· Part II extends this commitment across our entire peptide portfolio.

These achievements amplify our dedication to producing high-quality peptide Active Pharmaceutical Ingredients (APIs) and our continuous efforts to meet and exceed industry standards. Grateful for our team’s hard work and dedication!

In the 7th edition of the Trifermed Awards for social impact in healthcare on the 19th September, Antonio Parente, founder and president of BCN Peptides, received the Professional Trajectory Award.

We are grateful to Trifermed for recognizing his accomplishments and contributions to improving people’s health, it inspires us to continue our mission of making a positive difference in the healthcare industry.

This represents a huge adknowledgement of his and our values and compromise towards pharmaceutical and biotechnological research for a better healthcare in our society!

You can find the interview below: